Diabetic Mouse Retinal Microvascular Endothelial Cells

Cat.No.: CSC-C9315J

Species: Mouse

Source: Retina; Eye

Cell Type: Endothelial Cell; Microvascular Cell

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-C9315J
Description
Diabetic Mouse Retinal Microvascular Endothelial Cells from Creative Bioarray are isolated from the retinal of Diabetic (db/db) mice. Diabetic Mouse Retinal Microvascular Endothelial Cells are grown in T25 tissue culture flasks pre-coated with gelatin-based solution for 2 min and incubated in Creative Bioarray’s Culture Complete Growth Medium generally for 3-7 days. Cultures are then expanded. Prior to shipping, cells at passage 3 are detached from flasks and immediately cryopreserved in vials. Each vial contains at least 0.5×10^6cells per ml. The method we use to isolate primary endothelial cells was developed based on a combination of established and our proprietary methods. These cells are pre-coated with PECAM-1 antibody, following the application of magnetic beads pre-coated with secondary antibody.
Species
Mouse
Source
Retina; Eye
Cell Type
Endothelial Cell; Microvascular Cell
Disease
Diabetes
Storage
Liquid Nitrogen (-180 °C).
Quality Control
Diabetic Mouse Retinal Microvascular Endothelial Cells are tested for expression of markers using antibody, VE-cadherin; AF1002 or CD31/PECAM-1 by immunofluorescence staining or FACS. Cells are negative for bacteria, yeast, fungi and mycoplasma. Cells can be expanded for 3-7 passages at a split ratio of 1:2 under the cell culture conditions specified by Creative Bioarray. Repeated freezing and thawing of cells is not recommended.
Storage and Shipping
Creative Bioarray ships frozen cells on dry ice. On receipt, immediately transfer frozen cells to liquid nitrogen (-180 °C) until ready for experimental use. Never can cells be kept at -20 °C.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Diabetic Mouse Retinal Microvascular Endothelial Cells (RMECs) are primary endothelial cells obtained from mouse retinal microvasculature of diabetes animal models induced by streptozotocin or spontaneous diabetic mice. The cells phenotypically and physiologically mimic characteristics observed in diabetes-related microvascular dysfunction such as diabetic retinopathy.

Morphologically, diabetic mouse RMECs exhibit a typical cobblestone-like endothelial appearance and form confluent monolayers under standard culture conditions. They differ from retinal endothelial cells of non-diabetic animals by displaying a dysfunctional endothelial barrier, disrupted tight junctions, and increased permeability. diabetic mouse RMECs also show altered expression of endothelial cell markers such as vascular endothelial (VE)-cadherin and Cluster of Differentiation 31 (CD31). Moreover, they upregulate pro-inflammatory cytokines, cell adhesion molecules, and pathways associated with oxidative stress.

Endothelial cell inflammation, leukostasis, angiogenesis, and apoptosis are amongst the different mechanisms of diabetic retinopathy that can be studied using diabetic mouse RMECs. In addition, they are utilized to understand hyperglycemia-induced pathways including vascular endothelial growth factor (VEGF), protein kinase C (PKC) and nuclear factor kappa B (NF-κB). Moreover, diabetic mouse RMECs can be used to screen potential anti-angiogenic and vasoprotective drugs.

Overexpression of Tff1 Inhibits HG-induced mRMEC Proliferation and Angiogenesis

Diabetic retinopathy (DR) is one of the microvascular complications of diabetes, however, molecular mechanisms of vascular dysfunction, especially endothelial dysfunction in DR are not well understood. Zhang's team developed diabetic retinopathy animal model in mice and cell model in mouse retinal microvascular endothelial cells (mRMECs) to explore the effect of Trefoil factor family 1 (Tff1) in DR.

To understand the function of Tff1 in diabetic retinopathy (DR)-associated endothelial dysfunction, mRMECs were exposed to high glucose (HG, 25 mM). The results showed that HG markedly decreased Tff1 expression, therefore, Tff1 was overexpressed followed by efficiency tested by RT-qPCR and western blot (Fig. 1A, B). Then CCK-8 and EdU assays were performed and data showed that proliferation caused by HG was significantly inhibited by Tff1 overexpression (Fig. 1C, D). Consistently, tube formation assay results showed that angiogenesis promoted by HG was also attenuated after upregulation of Tff1 (Fig. 1E). Moreover, RT-qPCR results showed that overexpression of Tff1 significantly decreased the mRNA expression of VEGFA and CD34 (Fig. 1F). Overall, these data indicated that Tff1 could negatively regulate HG-induced endothelial proliferation and angiogenesis in DR.

Overexpression of Tff1 inhibits HG-induced mRMEC proliferation and angiogenesis.

Fig. 1. Overexpression of Tff1 inhibits HG-induced mRMEC proliferation and angiogenesis (Zhang W, Zhang D G, et al., 2022).

Ask a Question

Write your own review

For research use only. Not for any other purpose.

Hot Products